Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
- PMID: 33143790
- PMCID: PMC7855004
- DOI: 10.1017/S003329172000389X
Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
Abstract
Background: Scientific interest in the therapeutic effects of classical psychedelics has increased in the past two decades. The psychological effects of these substances outside the period of acute intoxication have not been fully characterized. This study aimed to: (1) quantify the effects of psilocybin, ayahuasca, and lysergic acid diethylamide (LSD) on psychological outcomes in the post-acute period; (2) test moderators of these effects; and (3) evaluate adverse effects and risk of bias.
Methods: We conducted a systematic review and meta-analysis of experimental studies (single-group pre-post or randomized controlled trials) that involved administration of psilocybin, ayahuasca, or LSD to clinical or non-clinical samples and assessed psychological outcomes ⩾24 h post-administration. Effects were summarized by study design, timepoint, and outcome domain.
Results: A total of 34 studies (24 unique samples, n = 549, mean longest follow-up = 55.34 weeks) were included. Classical psychedelics showed significant within-group pre-post and between-group placebo-controlled effects on a range of outcomes including targeted symptoms within psychiatric samples, negative and positive affect-related measures, social outcomes, and existential/spiritual outcomes, with large between-group effect in these domains (Hedges' gs = 0.84 to 1.08). Moderator tests suggest some effects may be larger in clinical samples. Evidence of effects on big five personality traits and mindfulness was weak. There was no evidence of post-acute adverse effects.
Conclusions: High risk of bias in several domains, heterogeneity across studies, and indications of publication bias for some models highlight the need for careful, large-scale, placebo-controlled randomized trials.
Keywords: Anxiety; LSD; ayahuasca; depression; meta-analysis; psilocybin; psychedelics; psychological effects.
Conflict of interest statement
Conflicts of Interest
In the prior 12 months, Charles L. Raison has served as a consultant for Usona Institute, Alkermes and Shire. All other authors declare that there is no conflict of interest.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7855004/bin/nihms-1635180-f0001.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7855004/bin/nihms-1635180-f0002.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7855004/bin/nihms-1635180-f0003.gif)
Similar articles
-
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.Expert Rev Clin Pharmacol. 2018 Sep;11(9):889-902. doi: 10.1080/17512433.2018.1511424. Epub 2018 Aug 23. Expert Rev Clin Pharmacol. 2018. PMID: 30102078 Review.
-
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.J Psychopharmacol. 2022 Jan;36(1):20-30. doi: 10.1177/02698811211044688. Epub 2021 Sep 14. J Psychopharmacol. 2022. PMID: 34519567
-
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Psychopharmacology (Berl). 2021 Feb;238(2):341-354. doi: 10.1007/s00213-020-05719-1. Epub 2021 Jan 11. Psychopharmacology (Berl). 2021. PMID: 33427944 Free PMC article. Review.
-
[Efficacy of psychedelics in psychiatry, a systematic review of the literature].Encephale. 2021 Aug;47(4):376-387. doi: 10.1016/j.encep.2020.12.002. Epub 2021 Apr 20. Encephale. 2021. PMID: 33888297 French.
-
Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.Psychiatry Res. 2024 May;335:115886. doi: 10.1016/j.psychres.2024.115886. Epub 2024 Mar 28. Psychiatry Res. 2024. PMID: 38574699 Review.
Cited by
-
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.Sci Rep. 2024 Feb 7;14(1):3159. doi: 10.1038/s41598-024-52967-8. Sci Rep. 2024. PMID: 38326432 Free PMC article. Clinical Trial.
-
Psychedelics for Alzheimer's Disease Palliative Care.Adv Psychiatry Behav Health. 2022 Sep;2(1):37-46. doi: 10.1016/j.ypsc.2022.06.001. Epub 2022 Sep 9. Adv Psychiatry Behav Health. 2022. PMID: 37786540 Free PMC article. No abstract available.
-
Alternative beliefs in psychedelic drug users.Sci Rep. 2023 Sep 30;13(1):16432. doi: 10.1038/s41598-023-42444-z. Sci Rep. 2023. PMID: 37777572 Free PMC article.
-
Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic.Sci Rep. 2023 Sep 11;13(1):14052. doi: 10.1038/s41598-023-41199-x. Sci Rep. 2023. PMID: 37696900 Free PMC article.
-
Understanding the Mechanisms of Action and Effects of Drugs of Abuse.Molecules. 2023 Jun 24;28(13):4969. doi: 10.3390/molecules28134969. Molecules. 2023. PMID: 37446631 Free PMC article. Review.
References
-
- Becker B (1988). Synthesizing standardized mean-change measures. British Journal of Mathematical and Statistical Psychology, 41, 257–278.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous